Brokerages Set Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) PT at $90.93
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Get Free Report) has received an average recommendation of “Moderate Buy” from the fifteen brokerages that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and fourteen have issued a buy recommendation on the company. The average twelve-month target price among […]
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Get Free Report) has received an average recommendation of “Moderate Buy” from the fifteen brokerages that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and fourteen have issued a buy recommendation on the company. The average twelve-month target price among […]
